153 related articles for article (PubMed ID: 35593014)
1. Chemotherapy-induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention.
Degliuomini MD; Armstrong K; Mauguen A; Slotkin EK; Roberts SS; Dunkel IJ; Clouser M; Ortiz MV; Soff GA
Pediatr Blood Cancer; 2022 Oct; 69(10):e29776. PubMed ID: 35593014
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours.
Zhang X; Chuai Y; Nie W; Wang A; Dai G
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012035. PubMed ID: 29178132
[TBL] [Abstract][Full Text] [Related]
3. Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: a descriptive study of a large outpatient oncology practice database, 2000-2007.
Wu Y; Aravind S; Ranganathan G; Martin A; Nalysnyk L
Clin Ther; 2009; 31 Pt 2():2416-32. PubMed ID: 20110050
[TBL] [Abstract][Full Text] [Related]
4. Risk and consequences of chemotherapy-induced thrombocytopenia in US clinical practice.
Weycker D; Hatfield M; Grossman A; Hanau A; Lonshteyn A; Sharma A; Chandler D
BMC Cancer; 2019 Feb; 19(1):151. PubMed ID: 30764783
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chemotherapy-induced thrombocytopenia in patients with non-hematologic malignancies.
Kuter DJ
Haematologica; 2022 Jun; 107(6):1243-1263. PubMed ID: 35642485
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and Management of Thrombocytopenia in Metastatic Colorectal Cancer Patients Receiving Chemotherapy: Secondary Analysis of Data From Prospective Clinical Trials.
Kilpatrick K; Shaw JL; Jaramillo R; Toler A; Eisen M; Sangaré L; Soff GA
Clin Colorectal Cancer; 2021 Jun; 20(2):170-176. PubMed ID: 33281065
[TBL] [Abstract][Full Text] [Related]
7. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies.
Al-Samkari H; Parnes AD; Goodarzi K; Weitzman JI; Connors JM; Kuter DJ
Haematologica; 2021 Apr; 106(4):1148-1157. PubMed ID: 32499239
[TBL] [Abstract][Full Text] [Related]
8. Management of Thrombocytopenia in Cancer Patients.
Mones JV; Soff G
Cancer Treat Res; 2019; 179():139-150. PubMed ID: 31317485
[TBL] [Abstract][Full Text] [Related]
9. Dose escalation study of an anti-thrombocytopenic agent in patients with chemotherapy induced thrombocytopenia.
Levin RD; Daehler M; Grutsch JF; Hall JL; Gupta D; Lis CG
BMC Cancer; 2010 Oct; 10():565. PubMed ID: 20955619
[TBL] [Abstract][Full Text] [Related]
10. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):714-720. PubMed ID: 30293399
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis in patients with chemotherapy-induced thrombocytopenia and the effect of platelet transfusion.
Heubel-Moenen FCJI; Henskens YMC; Verhezen PWM; Wetzels RJH; Schouten HC; Beckers EAM
J Thromb Haemost; 2019 Jul; 17(7):1073-1084. PubMed ID: 31033178
[TBL] [Abstract][Full Text] [Related]
12. Romiplostim for management of chemotherapy-induced thrombocytopenia.
Parameswaran R; Lunning M; Mantha S; Devlin S; Hamilton A; Schwartz G; Soff G
Support Care Cancer; 2014 May; 22(5):1217-22. PubMed ID: 24414994
[TBL] [Abstract][Full Text] [Related]
13. The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China.
Zhou S; Song B; Li C; Tang W; Zhang X; Jin X; Xu X; Wang Q; Zheng H; Fu J
Sci Rep; 2023 Feb; 13(1):3185. PubMed ID: 36823199
[TBL] [Abstract][Full Text] [Related]
14. Dose reductions and delays: limitations of myelosuppressive chemotherapy.
Cairo MS
Oncology (Williston Park); 2000 Sep; 14(9 Suppl 8):21-31. PubMed ID: 11033835
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy induced thrombocytopenia in pediatric oncology.
Tamamyan G; Danielyan S; Lambert MP
Crit Rev Oncol Hematol; 2016 Mar; 99():299-307. PubMed ID: 26811139
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled study of recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in patients with breast cancer receiving dose-intensive cyclophosphamide and doxorubicin.
Isaacs C; Robert NJ; Bailey FA; Schuster MW; Overmoyer B; Graham M; Cai B; Beach KJ; Loewy JW; Kaye JA
J Clin Oncol; 1997 Nov; 15(11):3368-77. PubMed ID: 9363868
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care.
Merjaneh N; Young J; Mangoli A; Olsen M; Setty B; Lane A; Nagarajan R; Pressey JG; Turpin B
Pediatr Blood Cancer; 2022 Jul; 69(7):e29548. PubMed ID: 34962714
[TBL] [Abstract][Full Text] [Related]
18. The incidence of thrombocytopenia in adult patients receiving chemotherapy for solid tumors or hematologic malignancies.
Shaw JL; Nielson CM; Park JK; Marongiu A; Soff GA
Eur J Haematol; 2021 May; 106(5):662-672. PubMed ID: 33544940
[TBL] [Abstract][Full Text] [Related]
19. Bleeding risks are higher in children versus adults given prophylactic platelet transfusions for treatment-induced hypoproliferative thrombocytopenia.
Josephson CD; Granger S; Assmann SF; Castillejo MI; Strauss RG; Slichter SJ; Steiner ME; Journeycake JM; Thornburg CD; Bussel J; Grabowski EF; Neufeld EJ; Savage W; Sloan SR
Blood; 2012 Jul; 120(4):748-60. PubMed ID: 22538854
[TBL] [Abstract][Full Text] [Related]
20. Current issues with platelet transfusion in patients with cancer.
McCullough J
Semin Hematol; 2000 Apr; 37(2 Suppl 4):3-10. PubMed ID: 10831283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
